Validation of Five Seasons Sleep Tracking Mat for the Diagnosis of Obstructive Sleep Apnea
Key facts
- Where
- Shanghai, ChinaSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 70 years old?
Source: NCT06875479, who can take part
Where in China
- Shanghai Sixth People's HospitalShanghai, ChinaContact: Weijun Huang, Dr.Taking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Shanghai 6th People's Hospital
- Trial code
- NCT06875479
- Record updated
- 16 April 2025
- Original description
This study will evaluate and compare the diagnostic accuracy and effectiveness of the Five Seasons Sleep Tracking Mat with the gold standard, polysomnography.Read full original descriptionShow less
This study will evaluate and compare the diagnostic accuracy and effectiveness of the Five Seasons Sleep Tracking Mat with the gold standard, polysomnography.
Inclusion: Participants between 18 and 70 years, with potential symptoms of snoring at night, daytime sleepiness, or self-reported poor sleep quality, suspected of having OSA; Participants who are willing to undergo overnight PSG.
Exclusion: Participants with concurrent unstable respiratory diseases or other acute-phase respiratory illnesses; Participants using, at long term or currently, barbiturates, benzodiazepines, sedatives, or other medications that may affect sleep; Participants undergoing continuous positive airway pressure (CPAP) therapy or other sleep-related treatments on the study night; Participants with presence of severe cardiovascular or cerebrovascular diseases, or significant impairment of liver, kidney, or lung function; Participants coexisting insomnia, parasomnia, or other sleep disorders; Participants with psychiatric disorders; Participants with any other conditions deemed unsuitable for inclusion by the investigators; Participants refusing to sign the informed consent form; Participants unable to cooperate with the required examinations.